Gleason Score 3+4=7 Prostate Cancer with Minimal Pattern 4 Identified in Prostate Needle Biopsy Barely has Worse Pathological Outcomes

被引：0
|
作者：
Serrano, Antonio [1 ]
Melamed, Jonathan [2 ]
Ren, Qinghu [3 ]
Huang, Hongying [1 ]
Park, Kyung [1 ]
Flaifel, Abdallah [4 ]
Deng, Fangming [5 ]
机构：
[1] NYU Langone Hlth, New York, NY USA
[2] NYU, New York, NY USA
[3] NYU, Langone Med Ctr, New York, NY USA
[4] NYU, Sch Med, New York, NY USA
[5] NYU Med Ctr, New York, NY 10016 USA
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1011
引用
收藏
页码：969 / 971
页数：3
相关论文
共 50 条
  • [31] Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4+3 and Gleason 3+4 Tumors in a Population Based Cohort
    Wright, Jonathan L.
    Salinas, Claudia A.
    Lin, Daniel W.
    Kolb, Suzanne
    Koopmeiners, Joseph
    Feng, Ziding
    Stanford, Janet L.
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2702 - 2707
  • [32] Oncological outcomes in men on active surveillance with Gleason 3+4 prostate cancer
    Amin, A.
    Blazevski, A.
    Thompson, J.
    Stricker, P.
    BJU INTERNATIONAL, 2020, 125 : 86 - 86
  • [33] Re: Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3+4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance
    Iczkowski, Kenneth A.
    JOURNAL OF UROLOGY, 2018, 200 (04): : 905 - 905
  • [34] Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3+4=7 prostate cancer
    Flood, Trevor A.
    Schieda, Nicola
    Keefe, Daniel T.
    Breau, Rodney H.
    Morash, Chris
    Hogan, Kevin
    Belanger, Eric C.
    Mai, Kien T.
    Robertson, Susan J.
    VIRCHOWS ARCHIV, 2016, 469 (03) : 313 - 319
  • [35] Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer
    Kweldam, Charlotte F.
    Kummerlin, Intan P.
    Nieboer, Daan
    Steyerberg, Ewout W.
    Bangma, Chris H.
    Incrocci, Luca
    van der Kwast, Theodorus H.
    Roobol, Monique J.
    van Leenders, Geert J.
    MODERN PATHOLOGY, 2017, 30 (08) : 1126 - 1132
  • [36] Are Men with Gleason Score 3+4=7 Cancer on Biopsy Candidates for Active Surveillance?
    Epstein, Jonathan I.
    Tosoian, Jeff
    MODERN PATHOLOGY, 2017, 30 : 223A - 223A
  • [37] CONTEMPORARY PATIENTS WITH BIOPSY GLEASON 3+4 PROSTATE CANCER: ELIGIBILITY FOR ACTIVE SURVEILLANCE
    Kwon, Ohseong
    Lee, Hakmin
    Jo, Jung Ki
    Lee, Young Ik
    Oh, Jong Jin
    Lee, Sangchul
    Jeong, Seong Jin
    Byun, Seok-Soo
    Lee, Sang Eun
    Hong, Sung Kyu
    JOURNAL OF UROLOGY, 2015, 193 (04): : E515 - E515
  • [38] Risk of Gleason Score 3+4=7 prostate cancer upgrading at radical prostatectomy is significantly reduced by targeted versus standard biopsy
    De Luca, Stefano
    Fiori, Cristian
    Bollito, Enrico
    Garrou, Diletta
    Aimar, Roberta
    Cattaneo, Giovanni
    De Cillis, Sabrina
    Manfredi, Matteo
    Tota, Daniele
    Federica, Massa
    Passera, Roberto
    Porpiglia, Francesco
    MINERVA UROLOGICA E NEFROLOGICA, 2020, 72 (03) : 360 - 368
  • [39] Are Men with Gleason Score 3+4=7 Cancer on Biopsy Candidates for Active Surveillance?
    Epstein, Jonathan I.
    Tosoian, Jeff
    LABORATORY INVESTIGATION, 2017, 97 : 223A - 223A
  • [40] Gleason 4+3 Versus Gleason 3+4 Prostate Cancer: Still A Worse Prognostic Indicator Despite the Introduction of RAPC
    Broe, M.
    Forde, J.
    Burke, M.
    Shakeel, I.
    Lennon, G.
    Galvin, D.
    Mulvin, D.
    Quinlan, D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S384 - S384
12345